Insulet Corp: Form 10-K for the period ended Dec 31, 2025
Filed with the SEC on Feb 18, 2026 and accepted by EDGAR at Feb 18, 2026, 21:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $2.71bn | us-gaap:Revenues |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $768.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $1.94bn | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $301.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2025-01-01 to 2025-12-31 | $1.17bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $473.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $59.4m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $92.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $247.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $3.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $3.51 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 71,886,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $569.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $191.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $59.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2025-12-31 | $1.91bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $3.19bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $680.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $1.68bn | us-gaap:Liabilities |
| Current portion of debt | At period end2025-12-31 | $18.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $1.52bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-26-000028. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.